800.28美元3.91(0.49%)
2024/06/28更新
績效 / 1月7.75%
3月0.46%
1年16.44%
晨星評等 - 1.現金1.32%
- 2.股票8.29%
- 3.債券-0.13%
- 4.其他90.52%
- 1.美國90.51%
- 2.歐元區2.24%
- 3.加拿大2.24%
- 4.歐洲不包含歐元區1.97%
- 5.英國1.85%
- 1.Moderna Inc4.38%
- 2.Neurocrine Biosciences Inc4.35%
- 3.argenx SE ADR4.17%
- 4.Alnylam Pharmaceuticals Inc4.04%
- 5.Blueprint Medicines Corp4.01%
- 6.Biomarin Pharmaceutical Inc3.97%
- 7.Sarepta Therapeutics Inc3.71%
- 8.Regeneron Pharmaceuticals Inc3.71%
- 9.Vertex Pharmaceuticals Inc3.59%
- 10.Amgen Inc3.20%
- 1.現金1.32%
- 2.股票8.29%
- 3.債券-0.13%
- 4.其他90.52%
- 1.美國90.51%
- 2.歐元區2.24%
- 3.加拿大2.24%
- 4.歐洲不包含歐元區1.97%
- 5.英國1.85%
- 1.Moderna Inc4.38%
- 2.Neurocrine Biosciences Inc4.35%
- 3.argenx SE ADR4.17%
- 4.Alnylam Pharmaceuticals Inc4.04%
- 5.Blueprint Medicines Corp4.01%
- 6.Biomarin Pharmaceutical Inc3.97%
- 7.Sarepta Therapeutics Inc3.71%
- 8.Regeneron Pharmaceuticals Inc3.71%
- 9.Vertex Pharmaceuticals Inc3.59%
- 10.Amgen Inc3.20%